EUVIMEDEUVIMED entdecken
Crossref

Kidney phenotype and clinical course in children with AMN-related Imerslund-Gräsbeck syndrome: a multicenter cohort

Serim Pul, Neslihan Çiçek, Ceren Alavanda, Aysun Çaltık Yılmaz, Fatma Uzun, Sevcan Bakkaloğlu, İlknur Girişgen, Tülay Becerir, Mehtap Kaya, Serçin Güven, İbrahim Gökçe

Pediatric Nephrology · 17.11.2026

DOI: 10.1007/s00467-026-07623-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Nephrology, online erschienen am 17.11.2026. Verfasst von Serim Pul und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology, Ümraniye Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye. serimpolat@gmail.com. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney manifestations of Imerslund-Gräsbeck syndrome (IGS) caused by pathogenic AMN variants remain poorly characterized. We aimed to describe the kidney phenotype and clinical course in children with AMN-related IGS presenting with proteinuria.

Methods

This multicenter retrospective cohort included nine children with homozygous pathogenic AMN variants followed at six pediatric nephrology centers in Turkey. Initial presentations occurred between 2009 and 2024; clinical, laboratory, genetic, and follow-up data were reviewed.

Results

Median age at diagnosis was 41 months (range, 4–97), and median follow-up was 30 months (range, 12–171). Five patients presented with vitamin B12 deficiency–related manifestations, three with isolated urinary abnormalities, and one through family screening. Persistent subnephrotic-range proteinuria was present in all patients; median uPCR was 1.2 mg/mg at admission and 0.88 mg/mg at last follow-up. One patient had a 25% eGFR decline from 144 to 108 mL/min/1.73 m², but final eGFR remained >90 mL/min/1.73 m² in all patients. No patient developed stage 2 or more advanced CKD, nephrotic syndrome, or required kidney replacement therapy. Six patients received RAS inhibitors; changes in uPCR were heterogeneous, and treatment efficacy could not be determined. Eight patients carried homozygous c.208-2 A > G, whereas one harbored the novel c.354 G > A (p.Trp118*) variant.

Conclusions

In this multicenter cohort of children with AMN-related IGS presenting with proteinuria, persistent subnephrotic-range proteinuria was accompanied by generally preserved kidney function during the observed follow-up. Early genetic diagnosis may help avoid unnecessary kidney biopsy and inappropriate immunosuppressive treatment. Graphical Abstract A higher resolution version of the Graphical Abstract is available as Supplementary information . This image summarizes a study on kidney phenotype and clinical outcomes in children with AMN-related Imerslund-Gräsbeck Syndrome. It presents the study design, evaluation methods, key findings, and conclusion. The study cohort includes nine children from six Turkish centers with homozygous pathogenic AMN variants and proteinuria, followed for a median of 30 months. Evaluation involved proteinuria testing by dipstick and spot urine protein-to-creatinine ratio, kidney function assessment by serum creatinine and estimated glomerular filtration rate, genetic testing by next-generation sequencing and Sanger sequencing, and kidney biopsy in two patients. The recurrent c.208-2A>G variant was found in 88.9 percent of cases. Key findings indicate generally preserved kidney function during follow-up, persistent subnephrotic-range proteinuria, and nonspecific kidney biopsy results. None of the children developed stage 2 chronic kidney disease or nephrotic syndrome. The conclusion states that AMN-related Imerslund-Gräsbeck Syndrome is a heterogeneous and underrecognized cause of persistent subnephrotic-range proteinuria in children with generally preserved kidney function, suggesting that a genetics-first approach can avoid unnecessary kidney biopsies and inappropriate immunosuppressive treatments.

Schlagwörter

Stichwörter der Autor:innen

AlbuminuriaAmnionlessCobalaminImerslund-Gräsbeck syndromeProteinuriaProximal tubule

Autor:innen und Institutionen

  • Department of Pediatric Nephrology, Ümraniye Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye. serimpolat@gmail.com.
  • Department of Pediatric Nephrology, Marmara University Faculty of Medicine, Istanbul, Türkiye.
  • Department of Medical Genetics, Istanbul University Faculty of Medicine, Istanbul, Türkiye.
  • Department of Pediatric Nephrology, Ankara Etlik City Hospital, Ankara, Türkiye.
  • Department of Pediatric Nephrology, Elazığ City Hospital, Elazığ, Türkiye.
  • Department of Pediatric Nephrology, Gazi University Faculty of Medicine, Ankara, Türkiye.

Zitieren

APA

Pul, S., Çiçek, N., Alavanda, C., Yılmaz, A. Ç., Uzun, F., Bakkaloğlu, S., Girişgen, İ., Becerir, T., Kaya, M., Güven, S., & Gökçe, İ. (2026). Kidney phenotype and clinical course in children with AMN-related Imerslund-Gräsbeck syndrome: a multicenter cohort. Pediatric Nephrology. https://doi.org/10.1007/s00467-026-07623-w

Vancouver

Pul S, Çiçek N, Alavanda C, Yılmaz AÇ, Uzun F, Bakkaloğlu S, et al. Kidney phenotype and clinical course in children with AMN-related Imerslund-Gräsbeck syndrome: a multicenter cohort. Pediatric Nephrology. 2026. doi:10.1007/s00467-026-07623-w

BibTeX
@article{Pul2026,
  author = {Pul, Serim and Çiçek, Neslihan and Alavanda, Ceren and Yılmaz, Aysun Çaltık and Uzun, Fatma and Bakkaloğlu, Sevcan and Girişgen, İlknur and Becerir, Tülay and Kaya, Mehtap and Güven, Serçin and Gökçe, İbrahim},
  title = {Kidney phenotype and clinical course in children with AMN-related Imerslund-Gräsbeck syndrome: a multicenter cohort},
  journal = {Pediatric Nephrology},
  year = {2026},
  doi = {10.1007/s00467-026-07623-w}
}
Kostenlos starten →